Magnesium-lithium alloys developed for low temperature use

Three new magnesium-lithium alloys have been developed for application at cryogenic temperatures. These lightweight alloys have approximately doubled the tensile and yield strengths at room temperature of previously described magnesium-lithium alloys

Development of light weight magnesium alloys for low temperature applications Final summary report, Mar. 21, 1966 - Mar. 25, 1967

Fabrication of light weight aluminum alloys for cryogenic application

Development of Light Weight Magnesium Alloys for Low Temperature Applications Annual Progress Report, 19 Jun. 1964 - 18 Jun. 1965

Lightweight, wrought magnesium alloys for high strength and ductility and low notch sensitivity applications at cryogenic temperature

Development of light weight magnesium alloys for low temperature applications Annual progress report, Jun. 19, 1965 - Mar. 20, 1966

Lightweight magnesium alloys for cryogenic application

Rapid growth of metallic fibers by partitioning sulfur in a copper-iron sulfide mineral /

Bibliographical references included.Mode of access: Internet

Regulatory T cells in the treatment of disease

International audienceRegulatory T (Treg) cells suppress inflammation and regulate immune system activity. In patients with systemic or organ-specific autoimmune diseases or those receiving transplanted organs, Treg cells are compromised. Approaches to strengthen Treg cell function, either by expanding them ex vivo and reinfusing them or by increasing the number or capacity of existing Treg cells, have entered clinical trials. Unlike the situation in autoimmunity, in patients with cancer, Treg cells limit the antitumour immune response and promote angiogenesis and tumour growth. Their immunosuppressive function may, in part, explain the failure of many immunotherapies in cancer. Strategies to reduce the function and/or number of Treg cells specifically in tumour sites are being investigated to promote antitumour immunity and regression. Here, we describe the current progress in modulating Treg cells in autoimmune disorders, transplantation and cancer